Publications:  Miss Glenda Scandura

Wagner T, Scandura G, Roe A, Beltran L, Shamash J, Alfrangis C, Daugaard G, Grantham M et al.(2020). Prospective molecular and morphological assessment of testicular prepubertal-type teratomas in postpubertal men. Modern Pathology vol. 33, (4) 713-721.

Xu L, Mao X, Grey A, Scandura G, Guo T, Burke E, Marzec J, Abdu S et al.(2020). Reply by Authors. The Journal of urology vol. 203, (1) 81-82.

Scandura G, Wagner T, Beltran L, Alifrangis C, Shamash J, Berney DM(2019). Pathological risk factors for metastatic disease at presentation in testicular seminomas with focus on the recent pT changes in AJCC TNM eighth edition. Human Pathology vol. 94, 16-22.

Xu L, Mao X, Grey A, Scandura G, Guo T, Burke E, Marzec J, Abdu S et al.(2019). Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells. The Journal of Urology vol. 203, 101097JU000000000000-101097JU000000000000.

Guo T, Wang Y, Mao X, Xu L, Marzec J, Burke E, Scandura G, Stankiewicz E et al. (2019). Abstract 2580: Investigation of plasma exosomal miRNA as a biomarker and its potential function in prostate cancer castration resistant development. 2580-2580.

Yeste-Velasco M, Guo T, Mao X, Stankiewicz E, Scandura G, Li H, Wang CS, Kudahetti S et al.(2019). The potential of brentuximab vedotin, alone or in combination with current clinical therapies, in the treatment of testicular germ cell tumors. Am J Cancer Res vol. 9, (5) 855-871.

Scandura G, Verrill C, Protheroe A, Joseph J, Ansell W, Sahdev A, Shamash J, Berney DM(2018). Incidentally detected testicular lesions <10 mm in diameter: can orchidectomy be avoided?. BJU International vol. 121, (4) 575-582.